Company
Headquarters: Zhuhai, China
Employees: 2,825
CN¥3.30 Billion
CNY as of Jan. 1, 2026
US$469.7 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $158.96 B |
| Vertex Pharmaceuticals Incorporated | $115.92 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $82.28 B |
| Marinomed Biotech AG | $70.11 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.
Guangdong VTR Bio-Tech Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300381 wb_incandescent